ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $52,600,000 | +62.0% | 565,956 | +3.8% | 0.01% | +57.1% |
| Q3 2021 | $32,476,000 | -18.3% | 545,357 | -6.5% | 0.01% | -22.2% |
| Q2 2021 | $39,758,000 | -3.9% | 582,965 | -2.3% | 0.01% | 0.0% |
| Q1 2021 | $41,393,000 | -30.4% | 596,527 | -22.9% | 0.01% | -35.7% |
| Q4 2020 | $59,444,000 | +1.9% | 773,709 | -0.8% | 0.01% | -12.5% |
| Q3 2020 | $58,359,000 | +7.9% | 780,307 | -9.2% | 0.02% | 0.0% |
| Q2 2020 | $54,105,000 | +55.3% | 859,499 | +3.6% | 0.02% | +33.3% |
| Q1 2020 | $34,850,000 | -23.2% | 829,772 | -17.0% | 0.01% | -7.7% |
| Q4 2019 | $45,393,000 | -0.8% | 999,407 | 0.0% | 0.01% | -7.1% |
| Q3 2019 | $45,743,000 | -11.7% | 999,407 | +13.1% | 0.01% | -12.5% |
| Q2 2019 | $51,827,000 | +70.1% | 883,963 | +30.1% | 0.02% | +60.0% |
| Q1 2019 | $30,465,000 | +42.5% | 679,550 | +23.8% | 0.01% | +25.0% |
| Q4 2018 | $21,374,000 | +180.8% | 548,744 | +231.7% | 0.01% | +300.0% |
| Q3 2018 | $7,613,000 | +185.1% | 165,421 | +144.7% | 0.00% | +100.0% |
| Q1 2018 | $2,670,000 | +16.3% | 67,591 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $2,296,000 | +33.2% | 67,591 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,724,000 | +51.2% | 67,591 | 0.0% | 0.00% | – |
| Q2 2017 | $1,140,000 | – | 67,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |